ALVEOFACT 50MG INJECTION

Content Reviewed By:

Written By:

• ALVEOFACT 50MG INJECTION is a crucial medication designed to address respiratory distress, particularly in premature infants. It works by replenishing surfactant, a naturally occurring substance in the lungs that reduces surface tension in the alveoli. These alveoli are tiny air sacs responsible for gas exchange.
• By decreasing surface tension, ALVEOFACT 50MG INJECTION prevents the alveoli from collapsing during exhalation. This ensures that the air sacs remain open, facilitating efficient oxygen uptake and carbon dioxide removal. The medication is composed of essential lipids and proteins, which are the building blocks of natural surfactant.
• This enhanced lung compliance achieved through ALVEOFACT 50MG INJECTION significantly eases the effort required for breathing. In conditions such as Respiratory Distress Syndrome (RDS) or other surfactant deficiencies, where the body doesn't produce enough surfactant, ALVEOFACT 50MG INJECTION acts as a vital supplement or replacement.
• Ultimately, surfactant replacement therapy with ALVEOFACT 50MG INJECTION is aimed at improving overall lung function and preventing potentially life-threatening breathing complications in vulnerable patients. It supports the respiratory system until the infant can produce enough surfactant on their own.
• ALVEOFACT 50MG INJECTION supports the respiratory system, ensuring adequate oxygenation and reducing the risk of long-term lung damage associated with RDS. This proactive approach helps to improve patient outcomes.

• ALVEOFACT 50MG INJECTION is a medication intended for use only when adequate ventilation and monitoring facilities are available. This ensures that your baby can receive the necessary respiratory support and close observation during and after administration.
• The medicine is administered via the intra-tracheal route, meaning it is delivered directly into the baby's trachea (windpipe). This method allows the medication to reach the lungs quickly and effectively.
• Your baby’s physician and nurse will continuously monitor vital signs, including heart rate and oxygen levels, to ensure the correct amount of oxygen is being delivered. This constant monitoring is crucial for detecting any potential adverse reactions or complications promptly.
• In the event of a slow heartbeat (bradycardia) or reduced oxygen levels in the blood (hypoxemia), the physician will temporarily stop the dosing. The administration of ALVEOFACT 50MG INJECTION will only be resumed once the baby's condition has stabilized and is deemed safe to continue.